Abstract

Patients who receive chemoradiotherapy or bioradiotherapy (CRT/BRT) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) often experience high toxicity rates interfering with oral intake, causing tube feeding (TF) dependency. International guidelines recommend gastrostomy insertion when the expected use of TF exceeds 4 weeks. We aimed to develop and externally validate a prediction model to identify patients who need TF≥4 weeks and would benefit from prophylactic gastrostomy insertion. A retrospective multicenter cohort study was performed in four tertiary head and neck cancer centers in the Netherlands. The prediction model was developed using data from University Medical Center Utrecht and the Netherlands Cancer Institute and externally validated using data from Maastricht University Medical Center and Radboud University Medical Center. The primary endpoint was TF dependency ≥4 weeks initiated during CRT/BRT or within 30 days after CRT/BRT completion. Potential predictors were extracted from electronic health records and radiotherapy dose-volume parameters were calculated. The developmental and validation cohort included 409 and 334 patients respectively. Multivariable analysis showed predictive value for pretreatment weight change, texture modified diet at baseline, ECOG performance status, tumor site, N classification, mean radiation dose to the contralateral parotid gland and oral cavity. The area under the receiver operating characteristics curve for this model was 0.73 and after external validation 0.62. Positive and negative predictive value for a risk of 90% or higher for TF dependency ≥4 weeks were 81.8% and 42.3% respectively. We developed and externally validated a prediction model to estimate TF-dependency ≥4 weeks in LAHNSCC patients treated with CRT/BRT. This model can be used to guide personalized decision-making on prophylactic gastrostomy insertion in clinical practice.

Highlights

  • Side effects of concurrent chemoradiotherapy or bioradiotherapy (CRT/BRT) often impair oral intake in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC), which may contribute to involuntary weight loss [1]

  • The present study describes the development and external validation of a prediction model to identify patients at risk for tube feeding (TF) dependency !4 weeks who would benefit from prophylactic gastrostomy insertion

  • Of note is the difference between the cancer centers with regard to the tube insertion protocol: In both University Medical Center Utrecht (UMCU) and MUMC þ gastrostomies were placed prophylactically in the majority of patients, Netherlands Cancer Institute (NCI) placed reactive gastrostomies and the Radboud University Medical Center (RUMC) prefers insertion of a nasogastric tube (NGT), instead of a gastrostomy tube

Read more

Summary

Introduction

Side effects of concurrent chemoradiotherapy or bioradiotherapy (CRT/BRT) often impair oral intake in patients with locally advanced (stage III/IV) head and neck squamous cell carcinoma (LAHNSCC), which may contribute to involuntary weight loss [1]. Patients fed via NGT experience more dislodgement and weight loss compared to patients with a gastrostomy tube [10]. Patients who receive chemoradiotherapy or bioradiotherapy (CRT/BRT) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) often experience high toxicity rates interfering with oral intake, causing tube feeding (TF) dependency. We aimed to develop and externally validate a prediction model to identify patients who need TF ! The prediction model was developed using data from University Medical Center Utrecht and the Netherlands Cancer Institute and externally validated using data from Maastricht University Medical Center and Radboud University Medical Center. Positive and negative predictive value for a risk of 90% or higher for TF dependency !4 weeks were 81.8% and 42.3% respectively

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call